Researchers at MD Anderson Cancer Center in Houston, Texas have identified key tumor microenvironment features that may help predict which rare cancers respond to immunotherapy.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Tumor microenvironment features may predict immunotherapy response in rare cancers
MD Anderson Cancer Center Research institution
Cell Reports Medicine Publication venue
Rare Cancer Immunotherapy Prediction Research focus